Keywords: fda, accepts, debiopharm, trelstar, nda, filing, swiss

US FDA accepts Debiopharm's Trelstar NDA for filing

Article | 24 November 2008

Swiss drugmaker Debiopharm says that its New Drug Application for the six-month formulation of Trelstar (triptorelin pamoate) has been accepted ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Striant

Testosterone

Testoderm

Trelstar

triptorelin pamoate

Go to drug listing